NorthWestern Corporation (NWE) has begun patient enrollment for clinical trials of Regeneron Pharmaceutical’s drug ‘Kevzara’ to treat Covid-19 patients. Current NWE stock price is $58.52. REGN is at $547.52. #stockstowatch #pharma #stocks  https://t.co/4QYUMPR8tq